- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------------------
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
November 28, 2001
-----------------
Date of Report
BAXTER INTERNATIONAL INC.
-------------------------
(Exact name of registrant as specified in its charter)
Delaware
--------
(State or other jurisdiction of incorporation)
1-4448 36-0781620
- -------------------------------- ---------------------------------
(Commission file number) (IRS Employer Identification No.)
One Baxter Parkway, Deerfield, Illinois 60015
- --------------------------------------- --------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (847) 948-2000
- --------------------------------------------------------------------------------
Page 1 of 7
Item 5. Other Events.
On November 28, 2001, Baxter Healthcare Corporation, a subsidiary of Baxter
International Inc., issued the attached press release relating to its
participation in the production of smallpox vaccine with Acambis Inc. at the
request of the U.S. government. The press release is filed as Exhibit 99 and
incorporated by reference.
Item 7. Exhibits.
99 Press Release dated November 28, 2001
Page 2 of 7
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BAXTER INTERNATIONAL INC.
-----------------------------------
(Registrant)
By: /S/ Jan S. Reed
-----------------------------------
Jan S. Reed
Corporate Secretary
Date: November 28, 2001
Page 3 of 7